4.8 Article

Current Evidence Base for Use of the Implantable Cardioverter-Defibrillator

Journal

CIRCULATION
Volume 128, Issue 2, Pages 172-183

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.112.000547

Keywords

guideline; implanted cardioverter-defibrillators; risk

Funding

  1. Sanofi Aventis
  2. Cardiome
  3. BMS
  4. BI
  5. Johnson Johnson
  6. Pfizer
  7. St. Jude Medical
  8. Boston-Scientific
  9. Medtronic
  10. Biotronik
  11. Sorin

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available